title: Patients receiving quinolones and cyclosporine after heart transplantation.
abstract: Six patients required fluorinated quinolone therapy for a variety of infections after heart transplantation. In contrast to findings in a previous report, none of the patients showed any evidence of nephrotoxicity or required a significant change in cyclosporine dose during the treatment period.
authors.affiliation: Stritch School of Medicine, Loyola University of Chicago, Maywood, IL 60153.
authors.forename: J A
authors.initials: JA
authors.lastname: Robinson
authors.forename: F R
authors.initials: FR
authors.lastname: Venezio
authors.forename: M R
authors.initials: MR
authors.lastname: Costanzo-Nordin
authors.forename: R
authors.initials: R
authors.lastname: Pifarre
authors.forename: P J
authors.initials: PJ
authors.lastname: O'Keefe
mesh_terms: D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D009643:Norfloxacin / Q000627:therapeutic use*
chemical_list: D003524:Cyclosporins; D002939:Ciprofloxacin; D009643:Norfloxacin